Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Bayer's Precose

Executive Summary

Bayer's Precose: Endocrinologic & Metabolic Drugs Advisory Committee will discuss NDA 20-482 for Bayer's acarbose for the treatment of non-insulin dependent diabetes mellitus on June 1. The E&M advisory committee recommended not to approve the product at a meeting in 1991. Bayer's U.S. subsidiary resubmitted the NDA in November. The meeting will take place at the Holiday Inn, 8777 Georgia Ave., Silver Spring, Md., beginning at 8 a.m...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026126

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel